Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event.
El-Kassas M, Elbehiry S, Rezk E, Omran D, Sherief A, Eltabbakh M, Moaz I, Ahan AT, Abdalgaber M, Khalil H, Alboraie M, Fouly AE, Aboul-Ezz M, Wahb A, Madkour A.
El-Kassas M, et al. Among authors: eltabbakh m.
Clin Res Hepatol Gastroenterol. 2022 Dec;46(10):102042. doi: 10.1016/j.clinre.2022.102042. Epub 2022 Oct 22.
Clin Res Hepatol Gastroenterol. 2022.
PMID: 36283614
No abstract available.